Prognostic Value of Residual Node Involvement in Operable Breast Cancer after Induction Chemotherapy

被引：0
|
作者：
Hervé Curé
Sophie Amat
Frédérique Penault-Llorca
Guillaume le Bouëdec
Jean-Pierre Ferrière
Marie-Ange Mouret-Reynier
Fabrice Kwiatkowski
Viviane Feillel
Jacques Dauplat
Philippe Chollet
机构：
[1] Centre Jean Perrin,
[2] INSERM U484,undefined
来源：
Breast Cancer Research and Treatment | 2002年 / 76卷
关键词：
breast cancer; long-term effect; neoadjuvant chemotherapy; node involvement; prognostic factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The purpose of this retrospective study was to evaluate the influence of axillary disease on patients' survival after neoadjuvant chemotherapy and to assess patient and tumor characteristics associated with post-chemotherapy axillary involvement.
引用
收藏
页码：37 / 45
页数：8
相关论文
共 50 条
  • [31] Role of ultrasonography to detect axillary node involvement in operable breast cancer
    Vaidya, JS
    Vyas, JJ
    Thakur, MH
    Khandelwal, KC
    Mittra, I
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (02): : 140 - 143
  • [32] Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy
    Ai, Xiang
    Liao, Xin
    Wang, Minghao
    Hu, Ying
    Li, Junyan
    Zhang, Yi
    Tang, Peng
    Jiang, Jun
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [33] Prognostic value of the ratio of positive axillary lymph node after neoadjuvant chemotherapy in Peruvian patients with breast cancer
    Vidaurre, T.
    Calderon, M.
    Mantilla, R.
    Vigil, C. E.
    Leon, M.
    Mas, L.
    Montanez, M.
    Neciosup, S. P.
    Gomez, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer:: the role of clinical response
    Pierga, JY
    Mouret, E
    Laurence, V
    Diéras, V
    Savigioni, A
    Beuzeboc, P
    Dorval, T
    Palangié, T
    Jouve, M
    Pouillart, P
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (08) : 1089 - 1096
  • [35] Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy
    Peintinger, Florentia
    Sinn, Bruno
    Hatzis, Christos
    Albarracin, Constance
    Downs-Kelly, Erinn
    Morkowski, Jerzy
    Gould, Rebekah
    Symmans, W. Fraser
    MODERN PATHOLOGY, 2015, 28 (07) : 913 - 920
  • [36] Prognostic Value of Genomic Analysis after Neoadjuvant Chemotherapy for Breast Cancer
    Mayer, E. L.
    Shak, S.
    Miller, K.
    Rugo, H.
    Carey, L.
    Ryabin, N.
    Pomeroy, C.
    Yoshizawa, C.
    Winer, E. P.
    Burstein, H. J.
    CANCER RESEARCH, 2010, 70
  • [37] Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer
    Ellis, P
    Smith, I
    Ashley, S
    Walsh, G
    Ebbs, S
    Baum, M
    Sacks, N
    McKinna, J
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 107 - 114
  • [38] Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study
    Gottipati, S.
    Earl, H. M.
    Yau, C.
    Cameron, D. A.
    Abraham, J.
    Hayward, L.
    Reyal, F.
    Osdoit, M.
    Sonke, G. S.
    Wesseling, J.
    Boughey, J.
    Goetz, M. P.
    DeMichele, A.
    Pusztai, L.
    Sharma, P.
    Martin Jimenez, M.
    Lopez-Tarruella Cobo, S.
    Del Monte-Millan, M.
    Symmans, F.
    Mukhtar, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S325 - S326
  • [39] Prognostic impact of neoadjuvant chemotherapy induced neutropenia on operable breast cancer
    韩芸蔚
    China Medical Abstracts(Surgery), 2012, 21 (01) : 6 - 6
  • [40] Node Micrometastases Detection After Neoadjuvant Chemotherapy in Breast Cancer: Is It of Clinical Value?
    Ziogas, Dimosthenis
    Harissis, Haralampos
    Batsis, Charalabos
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (03) : 933 - 934
12345